IMM 2.70% 38.0¢ immutep limited

primatron, page-2

  1. 313 Posts.
    You should understand that these results are no surprise to the Biomedical community and also the investment community.

    What should be strongly in your mind is taht the rights to CVac were not taken up by Biomira. They would have had all the data to review before making this decision.

    You may like to "believe" in PRR and CVac but facts are that they have no partner, no money and the CVAc results are not significant.

    PRR may succeed in getting trader hype and share price movement but ultimately the company is doomed with the business model that says:

    TRUST US
    WE BELIEVE OUR IP IS GOOD
    IT WILL BE OVER THREE YEARS FURTHER UNTIL WE ARE SURE
    THERE IS NO PROSPECT OF REVENUE FOR FOUR YEARS
    SO KEEP GIVING US YOUR MONEY.

    THE KNOWLEDGABLE INVESTMENT COMMUNITY HAS SAIS NO WAY!



 
watchlist Created with Sketch. Add IMM (ASX) to my watchlist
(20min delay)
Last
38.0¢
Change
0.010(2.70%)
Mkt cap ! $451.7M
Open High Low Value Volume
36.5¢ 38.3¢ 36.5¢ $219.2K 583.5K

Buyers (Bids)

No. Vol. Price($)
1 27027 37.0¢
 

Sellers (Offers)

Price($) Vol. No.
38.5¢ 58000 3
View Market Depth
Last trade - 16.10pm 29/03/2024 (20 minute delay) ?
Last
38.0¢
  Change
0.010 ( 2.43 %)
Open High Low Volume
37.0¢ 38.0¢ 37.0¢ 151143
Last updated 15.59pm 29/03/2024 ?
IMM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.